Receptor activator of nuclear factor κB ligand (RANKL) protein expression by B lymphocytes contributes to ovariectomy-induced bone loss
about
The Modulatory Effects of Mesenchymal Stem Cells on OsteoclastogenesisHigh Cholesterol Deteriorates Bone Health: New Insights into Molecular MechanismsThe role of estrogen and androgen receptors in bone health and diseaseImmune cells link obesity-associated type 2 diabetes and periodontitisRib fractures and death from deletion of osteoblast βcatenin in adult mice is rescued by corticosteroidsOsteocytes, not Osteoblasts or Lining Cells, are the Main Source of the RANKL Required for Osteoclast Formation in Remodeling BoneIdentification of B cells participated in the mechanism of postmenopausal women osteoporosis using microarray analysisBiologic therapies and bone loss in rheumatoid arthritis.Bone remodelling markers in rheumatoid arthritis.Activation of Toll‐like receptor 9 inhibits lipopolysaccharide‐induced receptor activator of nuclear factor kappa‐ B ligand expression in rat B lymphocytes.FoxO proteins restrain osteoclastogenesis and bone resorption by attenuating H2O2 accumulation.Osteocyte-derived RANKL is a critical mediator of the increased bone resorption caused by dietary calcium deficiency.SRT2104 extends survival of male mice on a standard diet and preserves bone and muscle massBiology of the RANKL-RANK-OPG System in Immunity, Bone, and Beyond.Physiological functions of osteoblast lineage and T cell-derived RANKL in bone homeostasis.Sex steroid actions in male boneDysregulated B cell expression of RANKL and OPG correlates with loss of bone mineral density in HIV infectionEstrogens and Androgens in Skeletal Physiology and Pathophysiology.Denosumab: targeting the RANKL pathway to treat rheumatoid arthritis.T-cells and B-cells in osteoporosisMinireview: nuclear receptor regulation of osteoclast and bone remodeling.Bone-immune cell crosstalk: bone diseases.B Cell Production of Both OPG and RANKL is Significantly Increased in Aged MiceMechanical environment change in root, periodontal ligament, and alveolar bone in response to two canine retraction treatment strategiesOsteoclasts: New InsightsTrauma-induced heterotopic bone formation and the role of the immune system: A reviewUnique Distal Enhancers Linked to the Mouse Tnfsf11 Gene Direct Tissue-Specific and Inflammation-Induced Expression of RANKL.New Insights Into Androgen and Estrogen Receptor Regulation of the Male Skeleton.Non-nuclear-initiated actions of the estrogen receptor protect cortical bone mass.Low bone mass and changes in the osteocyte network in mice lacking autophagy in the osteoblast lineage.Deletion of the Distal Tnfsf11 RL-D2 Enhancer That Contributes to PTH-Mediated RANKL Expression in Osteoblast Lineage Cells Results in a High Bone Mass Phenotype in MiceRANKL cytokine: from pioneer of the osteoimmunology era to cure for a rare diseaseOsteoimmunology: from mice to humansThe Effects of Androgens on Murine Cortical Bone Do Not Require AR or ERα Signaling in Osteoblasts and OsteoclastsPostmenopausal osteoporosis: the role of immune system cellsOsteoclasts-Key Players in Skeletal Health and Disease.The Interplay between the bone and the immune systemProduction of RANKL by Memory B Cells: A Link Between B Cells and Bone Erosion in Rheumatoid Arthritis.Basic biology of skeletal aging: role of stress response pathways.The Role of Inflammatory Cytokines, the RANKL/OPG Axis, and the Immunoskeletal Interface in Physiological Bone Turnover and Osteoporosis.
P2860
Q26773017-4986F205-B459-45BB-BC3F-4205794289B0Q26777956-D8C31194-5383-4400-941A-D91D5345D7D1Q27008878-3C327AEA-7468-46A9-A134-5E16AFD4365CQ27024696-535CE0A2-08E6-450E-900D-3A9591D050C2Q27316361-85DE5807-C1C0-487B-BC50-947544162643Q28267634-FA4A7AEB-DCC0-4991-9C2F-16BA91213189Q28652443-A99CA366-4348-494F-9A33-8CA633D81429Q30243911-02453B74-6241-4653-AEB3-7A794BD2A019Q33563068-E2DDEA88-8EEB-45A3-8189-F297E6DFC911Q33570032-684373AF-ADA4-4B5E-B5CD-09E868C62933Q33587373-A84E6C74-C3DA-4CF6-B0DA-71E25385F2B6Q34017216-9B508C8A-5DBC-4A8A-BB99-E1D6DA68DE7EQ34232012-A1AC25AF-7CE4-4337-B4EF-A783B133B55CQ34366449-EEF4A93C-51AF-44A0-8002-C8E6A3FFD1B9Q34369482-44A6F63F-761F-40FE-8E88-819BA2A74C33Q34437537-8C582CF2-F253-42EC-9DEC-3A81C7909C13Q34506677-897B0E47-D148-42F4-B19E-26750DF2D4A4Q34543980-C6CAB50B-8E51-4CD2-B91B-F1DD48D4933FQ34545263-BA05398F-F6D8-4702-846B-93DF1276DB6FQ35035665-E0767F15-005F-4875-8F50-98DFE1BC023DQ35054970-6C58A07D-7C75-4C26-8B96-6C3282BE55C5Q35592362-F4832F05-286A-46A7-A261-7959E42BDBE8Q35598428-5AC19147-9EE8-40B4-A3A7-D378B0909594Q35700179-307D0EF3-30F5-488E-B107-FE2675B27890Q35755039-CB99FBDF-4DE6-45A6-9DE1-4FEF190D178CQ36395829-8385FBB5-B47F-4A6F-B54C-E78D71252E5AQ36521118-5DAAC312-E65D-4A23-A5DD-57691135FF0AQ36593357-4C3EAE50-2632-4615-978D-6BDA5EEE547AQ36714891-56049984-A215-4D0E-A2D8-79525A336B85Q36785422-2AE0A113-7830-451C-8A59-5F2102FE79D0Q36808470-E8CF9C79-BFA2-45FB-8BF5-51C1D5D90D59Q36898545-C2AB46CA-D3DA-44C3-BC7A-3E4EA7A10303Q36911794-88A4161C-BB4D-4058-9F96-201899868376Q36912478-A456E926-471F-4170-9AF9-F271759050FDQ36914237-8BF770FC-77A8-462D-B30A-3F7495F875AFQ37036135-1E8ED906-5260-4A35-9E35-CEECD96E9374Q37052226-34772F74-9367-4636-946F-B24FD59FB781Q37115802-D1EAB2CF-D8E1-4C0D-A8D1-0CE091D28ACFQ37189212-C9F7E824-735D-415D-B755-B7CB3B77770CQ37287589-261ED2FD-149D-412C-B71B-D09956A0D0EA
P2860
Receptor activator of nuclear factor κB ligand (RANKL) protein expression by B lymphocytes contributes to ovariectomy-induced bone loss
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Receptor activator of nuclear ...... ovariectomy-induced bone loss
@ast
Receptor activator of nuclear ...... ovariectomy-induced bone loss
@en
type
label
Receptor activator of nuclear ...... ovariectomy-induced bone loss
@ast
Receptor activator of nuclear ...... ovariectomy-induced bone loss
@en
prefLabel
Receptor activator of nuclear ...... ovariectomy-induced bone loss
@ast
Receptor activator of nuclear ...... ovariectomy-induced bone loss
@en
P2093
P2860
P356
P1476
Receptor activator of nuclear ...... ovariectomy-induced bone loss
@en
P2093
Charles A O'Brien
Jeff D Thostenson
Jinhu Xiong
Maria Almeida
Melda Onal
Stavros C Manolagas
Xinrong Chen
P2860
P304
29851-29860
P356
10.1074/JBC.M112.377945
P407
P577
2012-07-10T00:00:00Z